A menopause blood test measures hormones such as FSH and oestradiol, but it cannot diagnose perimenopause in most women over 45. NICE recommends identifying menopause from symptoms and menstrual history alone at that age. A blood test helps in a few narrow situations, and outside them it is easy to misread.
Many women ask for a hormone test because they want certainty. The result looks precise and the number feels final. In perimenopause it is neither. Hormone levels swing from one cycle to the next, so a single result describes one morning, not a stage of life.
This guide explains what FSH, oestradiol and AMH actually show, who benefits from testing, and what to ask for at the appointment. It follows NICE guideline NG23 on menopause, updated in 2024, and the NHS advice built on it.
Menopause blood test: what it can and cannot show:
A menopause blood test is a laboratory measurement of reproductive hormones, most often follicle-stimulating hormone (FSH) and oestradiol. It shows how hard the pituitary is pushing the ovaries and how much oestrogen they still produce.
What it can show is that ovarian activity is low, and that matters when early menopause is suspected. What it cannot show is whether you are in early perimenopause, late perimenopause or the year before your final period. Those are clinical stages, defined by symptoms and bleeding patterns, not by a number on a printout.
What the hormones in the panel mean:
- FSH (follicle-stimulating hormone) is the pituitary signal to the ovaries. It rises as follicles become fewer, so a high value suggests the ovaries are winding down.
- Oestradiol is the main oestrogen made by the ovary. It rises and falls unpredictably in perimenopause and settles low after the final period.
- AMH (anti-Müllerian hormone) reflects the number of small follicles left. It estimates ovarian reserve, not the stage of the transition.
- Inhibin A and inhibin B are produced by growing follicles and fall as those follicles disappear.
Knowing the names helps you read a result. It does not turn a result into a diagnosis. A number is a clue, and the guideline treats it as one.
What NICE and the NHS recommend:
NICE guideline NG23 is explicit. In healthy people aged 45 or over with menopause symptoms, perimenopause and menopause are identified without laboratory tests. Menopause is confirmed when there has been no period for at least 12 months and you are not using hormonal contraception.
The guideline also lists the tests not to use in that age group to identify perimenopause or menopause: anti-Müllerian hormone, inhibin A, inhibin B, oestradiol, antral follicle count and ovarian volume. That is a long list, and it is deliberate.
FSH is handled separately, but only slightly differently. NICE advises against an FSH blood test to identify menopause if you take combined oestrogen and progestogen contraception, or a high-dose progestogen. It says to consider serum FSH in two groups only: people aged 40 to 45 with menopause symptoms and a change in their cycle, and people under 40 in whom menopause is suspected.
When a blood test is the right test:
Three situations justify testing, and each has a reason.
The first is early menopause, between 40 and 45. Symptoms plus a changed cycle raise the question, and an FSH level supports the diagnosis and moves the conversation towards treatment and bone protection.
The second is suspected menopause under 40. That is premature ovarian insufficiency (POI), meaning ovarian failure before the age of 40. It is a serious diagnosis, with consequences for fertility, bone and heart health, and it is never made on symptoms alone.
The third is uncertainty. After a hysterectomy the cycle gives no signal. A hormonal treatment can mask bleeding. Some symptoms overlap with thyroid disease. In each case a test answers a specific question instead of hunting for a stage.
A worked example makes the difference clear. A woman of 43 has had four months without a period, then two short cycles, and wakes at night sweating. Her GP orders FSH once. If it is raised, the diagnosis is supported and treatment can start. Her 47-year-old friend has the same symptoms but regular periods. For her the guideline says no blood test is needed, because the symptoms alone already identify perimenopause.
Why one normal FSH proves nothing:
Perimenopause is a period of instability rather than a steady decline. FSH can be high one month, normal the next, and high again three months later. Oestradiol moves in the opposite direction, and just as unpredictably.
A normal FSH in a 47-year-old with hot flushes and a shortened cycle therefore does not exclude perimenopause. An isolated high FSH in a 44-year-old with regular periods does not confirm it. A result only means something next to the cycle pattern and the symptoms.
This is the main reason guidelines discourage routine testing. It produces numbers that invite the wrong conclusion, and it either reassures people who should be watched or alarms people who are fine.
Premature ovarian insufficiency: the clearest exception:
Under 40, the rules change. NICE defines POI by menopause symptoms, including no periods or infrequent periods, plus elevated FSH on two blood samples taken 4 to 6 weeks apart. A single raised result is not enough.
The guideline adds that POI should not be diagnosed on one test, and that anti-Müllerian hormone should not be used routinely for diagnosis. If the picture remains unclear, the next step is referral to a specialist in menopause or reproductive medicine, not another blood draw.
| Test | What it measures | When NICE supports it |
|---|---|---|
| FSH | Pituitary signal that rises as ovarian follicles fall | Age 40 to 45 with symptoms and a changed cycle; under 40 if early menopause is suspected |
| Oestradiol | Oestrogen produced by the ovary | Not to identify menopause; used in some treatment monitoring |
| AMH | Reserve of small follicles | Not to diagnose menopause or POI |
| Thyroid function | Thyroid hormone, a common mimic of menopause symptoms | When symptoms could have another cause |
Hormonal contraception and home tests:
If you use a combined pill, a hormonal patch, a vaginal ring or a high-dose progestogen, the method supplies the hormones a test would measure. FSH says nothing useful about your own ovaries in that state, which is why NICE names this group directly.
A progestogen-only pill, an implant or a hormonal coil works differently, but bleeding on these methods is also a poor marker of the transition. A test result here is easy to misread, so it is worth asking what the number is meant to add.
Home and pharmacy tests usually measure FSH in urine. They have the same weakness as a single blood test, in a less precise version. A negative result does not rule out perimenopause, and a positive one does not confirm it. None of them is part of a guideline.
What to expect at the appointment:
A good consultation starts with questions, not with a blood form. Your doctor will ask when your periods changed and how, which symptoms appeared and when, whether you use hormonal contraception or another hormonal treatment, and whether there is a family history of early menopause.
Bring a record: the dates of your last six to twelve periods, the symptoms you noticed, and a few examples of how they affect sleep, work and mood. That history carries more weight than any single measurement.
Ask one question directly: "What will this test change?" If the answer is nothing, it is probably not needed. If the answer is "we need to rule out early menopause" or "your symptoms could be thyroid", the test has a purpose.
A test your doctor orders for a medical reason is normally covered by statutory health insurance in Germany. A private hormone panel you buy yourself is not, and its results are the hardest to read, because no clinical context is attached to them.
Treatment does not follow the number either. Hormone therapy is started and adjusted according to symptoms, not according to an FSH target, and no guideline sets one. A test that changes nothing about your care is information without a use.
Other tests, and the record that replaces a test:
When the picture is unclear, doctors look for other causes rather than for the menopause itself. Thyroid disease can produce palpitations, sweats, sleep problems and low mood. Iron deficiency causes fatigue and breathlessness. Vitamin D deficiency causes bone and muscle aching. Prolactin, liver function and a full blood count are sometimes added.
None of these diagnoses perimenopause. They remove the alternatives that would change the treatment.
A cycle diary and a symptom record show the pattern a blood test cannot. That pattern is what lets a clinician identify perimenopause at 45 and above, and what shows whether a treatment is working three months later. Record four things: the first day of each period, the days with hot flushes or night sweats, sleep quality and mood. Two months reveals a shape. Three months makes it hard to argue with.
When to see a doctor:
- Bleeding between periods, bleeding after sex, or any bleeding after 12 months without a period.
- Very heavy periods, flooding, or clots larger than usual.
- Suspected menopause before the age of 40, or a family history of early menopause.
- Symptoms that disrupt sleep, work or relationships for more than a few weeks.
- Palpitations with chest pain, fainting or breathlessness: seek urgent care the same day.
- Symptoms that could be thyroid, iron or another condition, before accepting a menopause explanation.